95 related articles for article (PubMed ID: 26688475)
1. [Diagnostic accuracy of malignancy risk index II in post-menopausal women with adnexal tumours].
Treviño-Báez JD; Cantú-Cruz JA; Medina-Mercado J; Abundis A
Cir Cir; 2016; 84(2):109-14. PubMed ID: 26688475
[TBL] [Abstract][Full Text] [Related]
2. The impact of size of the adnexal mass on the accuracy of frozen section diagnosis.
Geomini PM; Zuurendonk LD; Bremer GL; de Graaff J; Kruitwagen RF; Mol BW
Gynecol Oncol; 2005 Nov; 99(2):362-6. PubMed ID: 16051343
[TBL] [Abstract][Full Text] [Related]
3. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
4. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
Abdulrahman GO; McKnight L; Lutchman Singh K
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
[TBL] [Abstract][Full Text] [Related]
5. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Probably Benign Adnexal Masses in Postmenopausal Women.
Karakaya BK; Ozgu E; Kansu HC; Evliyaoglu O; Sarikaya E; Coskun B; Erkaya S
Rev Bras Ginecol Obstet; 2017 May; 39(5):229-234. PubMed ID: 28346954
[No Abstract] [Full Text] [Related]
7. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
[TBL] [Abstract][Full Text] [Related]
9. Transvaginal color Doppler assessment of venous flow in adnexal masses.
Alcázar JL; López-García G
Ultrasound Obstet Gynecol; 2001 May; 17(5):434-8. PubMed ID: 11380970
[TBL] [Abstract][Full Text] [Related]
10. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
van den Akker PA; Aalders AL; Snijders MP; Kluivers KB; Samlal RA; Vollebergh JH; Massuger LF
Gynecol Oncol; 2010 Mar; 116(3):384-8. PubMed ID: 19959215
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy index in the evaluation of patients with adnexal masses.
Clarke SE; Grimshaw R; Rittenberg P; Kieser K; Bentley J
J Obstet Gynaecol Can; 2009 May; 31(5):440-5. PubMed ID: 19604425
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index.
Enakpene CA; Omigbodun AO; Goecke TW; Odukogbe AT; Beckmann MW
J Obstet Gynaecol Res; 2009 Feb; 35(1):131-8. PubMed ID: 19215560
[TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy index in preoperative evaluation of pelvic masses.
Ashrafgangooei T; Rezaeezadeh M
Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
[TBL] [Abstract][Full Text] [Related]
15. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
16. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
17. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.
Ali N; Jan H; Van Trappen P; Nasreen F; Canizales A; Carroll MJ; Granowska M; Jacobs I; Britton KE
BJOG; 2003 May; 110(5):508-14. PubMed ID: 12742337
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonography.
Prömpeler HJ; Madjar H; Sauerbrei W; Lattermann U; Pfleiderer A
Obstet Gynecol; 1997 Mar; 89(3):428-33. PubMed ID: 9052599
[TBL] [Abstract][Full Text] [Related]
20. Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands.
Meys EM; Rutten IJ; Kruitwagen RF; Slangen BF; Bergmans MG; Mertens HJ; Nolting E; Boskamp D; Beets-Tan RG; van Gorp T
BMC Cancer; 2015 Jun; 15():482. PubMed ID: 26111920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
